Archive
Zogenix Receives FDA
Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extend-Release Capsules
October 25, 2013
Auspex Appoints Pratik Shah
As CEO And Expands Executive Team
October 17, 2013
Celator® Pharmaceuticals Receives U.S. Patent
On Proprietary Liposome Composition
August 29, 2013
Ocera Therapeutics Announces Completion
Of Merger With Tranzyme
July 15, 2013
CASMED Receives FDA Clearance for Next-Generation Vital Signs Monitor
And Blood Pressure Solution
June 4, 2013
Valeant Pharmaceuticals International, Inc.
To Acquire Bausch + Lomb For $8.7 Billion
May 27, 2013
Packaging Coordinators, Inc. Acquires AndersonBrecon
From AmerisourceBergen
May 13, 2013
Celator® Pharmaceuticals Raises $32.5 Million Completing A $39.3 Million Private Placement Financing
April 30, 2013
Thomas, McNerney & Partners Joins
With National Venture Capital Association And Other Industry Leaders In Briefing Congress
On Need For Policies That Will Support Investment In Medical Innovation
April 25, 2013
Tranzyme Pharma And Ocera Therapeutics Announce Merger Agreement
April 24, 2013
CASMED Announces FDA Approval
Of Next Generation FORE-SIGHT® Absolute Tissue Oximeter
April 17, 2013
The New England Journal
Of Medicine Publishes Clinical Study Of Minimally-Invasive Device for Treatment
Of Reflux Disease
February 21, 2013
Auspex Pharmaceuticals Closes $25 Million Series D Financing
November 8, 2012
Thomas, McNerney & Partners Invests
In Keystone Dental, Inc.
October 22, 2012
Cebix Announces Positive Results of ERSATTA Phase 1/2 Trial In Peripheral Neuropathy
October 17, 2012
Clarus Therapeutics Top-line Results Show Oral Testosterone Replacement Candidate, CLR-610, Meets Phase 3 Study Primary Efficacy Endpoint
September 25, 2012
Mallinckrodt Announces Definitive Agreement to Acquire CNS Therapeutics, Inc.
September 24, 2012
Clarus Therapeutics Strengthens Patent Estate
With Issuance Of A U.S. Patent Directed To Formulations And Method Of Use Of Clarus' Oral Testosterone Product
September 19, 2012
Locus Development, Inc. Merges
With InVitae Division Of Genomic Health
August 8, 2012
Zogenix Announces U.S. Food
And Drug Administration (FDA) Acceptance For Review Of Zohydro ER(TM) New Drug Application (NDA)
For Treatment Of Chronic Pain
July 16, 2012
The Leukemia & Lymphoma Society
And Celator Pharmaceuticals Announce
$5 Million Partnership To Support Phase 3 Development Of CPX-351 For AML
July 2, 2012
AxioMed Spine Corporation Receives CE Mark
For Freedom® Cervical Disc
May 15, 2012
Zogenix Submits New
Drug Application (NDA) To U.S. Food And Drug Administration (FDA) For
Zohydro(TM) For Treatment Of Chronic Pain
May 2, 2012
FDA Approves LINX®
System For The Treatment Of Reflux Disease
March 27, 2012
Torax Medical’s LINX® Reflux Management System Receives Unanimous Recommendation
From FDA Advisory Panel
January 13, 2012
VertiFlex®, Inc. Completes Enrollment
of The Superion® Pivotal IDE Clinical Trial
December 13, 2011
InnoPharma Completes $15
Million Series A Financing
December 1, 2011
CASMED Raises $15 Million
in Private Placement
June 9, 2011
Asante Solutions Receives
FDA Clearance for Pearl™ Insulin Pump
May 17, 2011
Thomas, McNerney & Partners
Expands Team and Moves West Coast Office to San Diego
February 23, 2011
Zogenix Announces Completion of Enrollment in ZX002 Phase 3 Efficacy Study
February 10, 2011
VertiFlex®, Inc. Announces Financing and New Investment Partner
February 1, 2011
Thomas, McNerney & Partners Promotes Two Members of its Investment Team
January 25, 2011
Boston Scientific to Acquire Atritech
January 19, 2011
Celator® Pharmaceuticals Raises $20 Million in Series D Financing
September 1, 2010
Sandoz to Acquire Oriel Therapeutics, Gaining Rights to Portfolio of Respiratory Products Targeting Asthma and COPD
April 19, 2010
Atritech Completes $30 Million Financing
March 25, 2009
Thomas, McNerney & Partners Promotes Three Members of Its Investment Team
January 8, 2009
Amarin Announces Private Placement for Up to $60 Million
May 14, 2008
Wuxi Pharmatech to Acquire Apptec Laboratory Services, Inc.
January 3, 2008
Pfizer to Acquire Coley Pharmaceutical Group
November 16, 2007
Tranzyme Pharma Closes New $20 Million Financing
November 1, 2007
Thomas, McNerney & Partners Expands Team on East and West Coasts
October 17, 2007
Thomas, McNerney & Partners Invests in Asante Solutions Inc.
January 12, 2007
Galil Medical, a Leader in Cryotherapy Solutions, Announces $52 Million Financing
December 11, 2006
Quinnova Pharmaceuticals, Inc. Completes $13.6 Million Series A Financing
November 28, 2006
Thomas, McNerney & Partners Closes $375 Million Life Science
& Medical Technology FundSeptember 6, 2006
Zogenix, Inc. Created Through Aradigm Asset Sale of Intraject® Needle-Free Technology
August 28, 2006
Thomas, McNerney & Partners Is Lead Investor in Osteobiologics, Acquired By Smith
& NephewJuly 11, 2006
Coley Pharmaceutical Group Sets Price for Initial Public Offering
August 10, 2005
Torax Medical Completes $10 Million Series B Financing
June 28, 2005
Pfizer, Coley Pharmaceutical Group Enter Into Exclusive Global License for the Development and Commercialization of Promune for Cancers
March 24, 2005
Thomas, McNerney & Partners Announces Pratik Shah, Ph.D. as New Venture Partner in San Francisco Office
November 8, 2004
Coley Pharmaceutical Group Raises $25 Million in Private Financing
September 29, 2004
Thomas, McNerney & Partners Invests in Clarus Therapeutics, Inc.
February 13, 2004
Osteobiologics, Inc. Closes $9.2 Million Financing
October 3, 2003
Coley Pharmaceutical Group Announces $35 Million Private Financing
August 25, 2003
Thomas, McNerney & Partners, LLC, Raises $216 Million for Its Inaugural Health Care Private Equity Fund
May 6, 2003